Filter Results:
(405)
Show Results For
- All HBS Web
(506)
- News (62)
- Research (405)
- Events (1)
- Multimedia (8)
- Faculty Publications (375)
Show Results For
- All HBS Web
(506)
- News (62)
- Research (405)
- Events (1)
- Multimedia (8)
- Faculty Publications (375)
Sort by
- January 2023
- Teaching Note
Identify the Health Care Venture
By: Regina E. Herzlinger and James Wallace
Teaching Note for HBS Exercise No. 323-061. View Details
- 8 Oct 2020
- Panel Discussion
Perspectives in Health: Verily Health: "The Long Fix—Lessons from the Front Lines of Health Care and Health Tech"
By: Regina E. Herzlinger and Vivian Lee
Herzlinger, Regina E., and Vivian Lee. Perspectives in Health: Verily Health: "The Long Fix—Lessons from the Front Lines of Health Care and Health Tech". Harvard Business School, October 8, 2020.
- March 2021
- Case
Humana (A)
By: Regina E. Herzlinger and Ashley Ifeadike
To implement a bold new strategy, Humana needed to decide how to prioritize the pillars; where to own and where to partner; how much risk is acceptable; and how to continue to deliver strong operational performance while implementing a new strategy. Had the firm made... View Details
Keywords: Health ＆ Wellness; Health Care Industry; Health Care Costs; Health Insurance; Health Insurance Marketplaces; Health Care and Treatment; Cost; Insurance; Strategy; Health Industry; United States
Herzlinger, Regina E., and Ashley Ifeadike. "Humana (A)." Harvard Business School Case 321-097, March 2021.
- Article
A Public Option Can Be a Triple Win for U.S. Healthcare
By: Regina E. Herzlinger and Richard Boxer
The United States needs to control healthcare costs and quality while reaching universal coverage. The strongest choice is a public option that allows people to choose between Medicare and private payers. But a public option needs sustainable financing mechanisms that... View Details
Keywords: Healthcare; Public Option; Universal Health Coverage; Health Care and Treatment; Cost Management; Quality; United States
Herzlinger, Regina E., and Richard Boxer. "A Public Option Can Be a Triple Win for U.S. Healthcare." Health Management, Policy and Innovation 4, no. 3 (December 2019).
- July 20, 2020
- Article
It's Time for a Bipartisan Health Plan for Employers and Employees
By: Regina E. Herzlinger and Richard Boxer
Herzlinger, Regina E., and Richard Boxer. "It's Time for a Bipartisan Health Plan for Employers and Employees." Harvard Business School Working Knowledge (July 20, 2020).
- April 1995 (Revised August 1995)
- Supplement
Empire Blue Cross and Blue Shield (G)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Supplements the (A) case. View Details
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (G)." Harvard Business School Supplement 195-222, April 1995. (Revised August 1995.)
- April 1995 (Revised August 1995)
- Case
Empire Blue Cross and Blue Shield (A)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Mounting financial losses and increasing public scrutiny present many challenges to the board of directors of a large nonprofit health insurer. This case series presents chronologically the increasing problems of the company. View Details
Keywords: Governing and Advisory Boards; Corporate Governance; Financial Condition; Organizational Culture; Problems and Challenges; Nonprofit Organizations; Insurance Industry
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (A)." Harvard Business School Case 195-216, April 1995. (Revised August 1995.)
- December 2013 (Revised February 2014)
- Supplement
Reinventing Brainlab (B)
By: Regina E. Herzlinger and Karol Misztal
The management of Germany's Brainlab AG, a leading provider of software-driven oncology and surgery solutions, needs to evaluate strategic options for proceeding without an exclusive hardware partner in its most profitable business segment. View Details
Keywords: Strategy; Information Infrastructure; Applications and Software; Medical Specialties; Information Technology Industry; Health Industry; Germany
Herzlinger, Regina E., and Karol Misztal. "Reinventing Brainlab (B)." Harvard Business School Supplement 314-054, December 2013. (Revised February 2014.)
- May 1994 (Revised February 2021)
- Background Note
Note on Reimbursement of Health Care Providers: Case-Based and Capitation Payment
By: Regina E. Herzlinger and Tom Nagle
Explains how managed care organizations use capitation as a payment method for providers. View Details
Keywords: Managed Care; Capitation; Health Care and Treatment; Insurance; Accounting; Financial Management; Health Industry; Insurance Industry
Herzlinger, Regina E., and Tom Nagle. "Note on Reimbursement of Health Care Providers: Case-Based and Capitation Payment." Harvard Business School Background Note 194-141, May 1994. (Revised February 2021.)
- August 2012 (Revised August 2014)
- Case
Cancer Treatment Centers of America® (A)
By: Regina E. Herzlinger and Natalie Kindred
Cancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who... View Details
Keywords: Cancer; Cancer Treatment; Health Care; Healthcare; Accountability; Outcomes; Outcomes Measurement; Outcomes Reporting; Hub And Spoke Cancer Care; Hub And Spoke; Hub-and-spoke; Focused Factory; Mission and Purpose; Private Ownership; For-Profit Firms; Health Disorders; Medical Specialties; Policy; Business Model; Expansion; Decision Choices and Conditions; Advertising; Health Care and Treatment; Innovation and Invention; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (A)." Harvard Business School Case 313-012, August 2012. (Revised August 2014.)
- March 2012 (Revised April 2017)
- Teaching Note
PAREXEL International Corp.: Stages of Innovation
By: Regina E. Herzlinger and Natalie Kindred
- August 2010 (Revised February 2014)
- Case
Vitalia Franchise
By: Regina E. Herzlinger and Beatriz Munoz-Seca
Cathy Hoffmann has rapidly grown her novel facilities for day care therapy for elders with mild cognitive and physical problems. But she needs to decide whether to franchise or own the next expansion. View Details
Keywords: Entrepreneurship; Health Care and Treatment; Growth and Development Strategy; Ownership Stake; Franchise Ownership; Expansion; Health Industry; Spain
Herzlinger, Regina E., and Beatriz Munoz-Seca. "Vitalia Franchise." Harvard Business School Case 311-035, August 2010. (Revised February 2014.)
- September 2008
- Background Note
Background on the Technology of Molecular Diagnostics
By: Regina E. Herzlinger and Jason Sanders
To be used as background reading for the "EXACT Sciences Corp.: Commercializing a Diagnostic Test" and "Diagnostic Genomics" cases, HBS nos. 308-090 and 309-040. View Details
Keywords: Health Testing and Trials; Technology; Biotechnology Industry; Medical Devices and Supplies Industry
Herzlinger, Regina E., and Jason Sanders. "Background on the Technology of Molecular Diagnostics." Harvard Business School Background Note 309-050, September 2008.
- March 2008
- Case
The Multiple Sclerosis Center of Atlanta
By: Regina E. Herzlinger and Alfred Martin
The Multiple Sclerosis Center of Atlanta wishes to expand beyond Georgia. The factors influencing this decision are discussed, including drug treatments currently available, and the impact of future drugs in the FDA pipeline as well as financing issues. View Details
Keywords: Decision Choices and Conditions; Financing and Loans; Health Care and Treatment; Health Disorders; Medical Specialties; Expansion; Health Industry; Atlanta
Herzlinger, Regina E., and Alfred Martin. "The Multiple Sclerosis Center of Atlanta." Harvard Business School Case 308-085, March 2008.
- January 2008 (Revised August 2012)
- Case
Retail Sales of Health Insurance: Blue Cross Blue Shield of Florida
By: Regina E. Herzlinger and Grady Clouse
The BCBS of Florida is contemplating whether to enter the consumer-driven health care market and if so, whether to target such groups—and individuals—and in which of its geographic markets, and how. View Details
- April 2005 (Revised August 2012)
- Supplement
MedCath Corporation (B)
By: Regina E. Herzlinger and Louisa Neissa
Supplements the (A) case. A rewritten version of an earlier case. View Details
Keywords: Medical Specialties; Market Entry and Exit; Service Delivery; Conflict and Resolution; Horizontal Integration; Medical Devices and Supplies Industry
Herzlinger, Regina E., and Louisa Neissa. "MedCath Corporation (B)." Harvard Business School Supplement 305-102, April 2005. (Revised August 2012.)
- June 15, 2021
- Article
Cutting the Gordian Knot of Employee Health Care Benefits and Costs: A Corporate Model Built on Employee Choice
By: Regina E. Herzlinger and Barak D. Richman
President Joe Biden’s promise to give every American access to affordable health insurance is well-intentioned, but his plan’s policy elements—a public option, a permanent expanded tax credit—require congressional approval and would expend significant political and... View Details
Keywords: Health Insurance; Health Insurance Marketplaces; Health Care Delivery; Health Care Financing; Health Care Industry; Health Care and Treatment; Insurance; Service Delivery; Cost Management; Health Industry; United States
Herzlinger, Regina E., and Barak D. Richman. "Cutting the Gordian Knot of Employee Health Care Benefits and Costs: A Corporate Model Built on Employee Choice." Health Affairs Blog (June 15, 2021).
- August 2012 (Revised August 2024)
- Case
ABC Pharmaceuticals
By: Regina E. Herzlinger and Erik R. Sparks
This case asks students to price a new drug that is in Stage II of its clinical trials. It contains detailed estimates of the time required and costs for all the steps needed to commercialize a drug in the U.S. Students will learn virtually all the steps required to... View Details
Keywords: Drug Development; Price; Product; Product Launch; Health Industry; Technology Industry; Pharmaceutical Industry
Herzlinger, Regina E., and Erik R. Sparks. "ABC Pharmaceuticals." Harvard Business School Case 313-041, August 2012. (Revised August 2024.)
- January 2010 (Revised August 2012)
- Supplement
Hospital for Special Surgery (B): Continuing Challenges of Growth
By: Regina E. Herzlinger and Laura Low Ah Kee
After its successful new U.K. venture, the Hospital for Special Surgery wants to do more of the same, without decimating its core New York City facility. The case provides considerable details about the different options it is exploring. View Details
Herzlinger, Regina E., and Laura Low Ah Kee. "Hospital for Special Surgery (B): Continuing Challenges of Growth." Harvard Business School Supplement 310-077, January 2010. (Revised August 2012.)